ライフサイエンスコーパス: radionuclide imaging

1 al resolution of MRI with the sensitivity of radionuclide imaging.

2 ercise and psychological stress testing with radionuclide imaging.

3 on late after reflow was similar for MCE and radionuclide imaging.

4 do not have myocardial perfusion defects on radionuclide imaging.

5 bits were killed, and the testes excised for radionuclide imaging.

6 s detected in 85% of torsed testes at US and radionuclide imaging.

7 with color Doppler US, power Doppler US, and radionuclide imaging.

8 and retention of the new cationic lipophilic radionuclide imaging agent 99mTc-Q12 are currently unkno

9 s in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent that can localize and non-inv

10 istributions of gamma- (and x-) ray-emitting radionuclide imaging agents or therapeutics.

11 he functional tumor characteristics shown by radionuclide imaging allow for more accurate staging and

12 spinal cord injuries using a combination of radionuclide imaging and clearance measurement.

13 was correctly diagnosed in 25% of cases with radionuclide imaging and in 60% of cases with US.

14 n human medical imaging, with an emphasis on radionuclide imaging and MRI.

15 Both radionuclide imaging and near-infrared fluorescent (NIRF

16 feasibility of using anti-PD-L1 antibody for radionuclide imaging and radioimmunotherapy and highligh

17 )}(2) a promising agent for peptide receptor radionuclide imaging and therapy of integrin-positive tu

18 ed as a possible target for peptide receptor radionuclide imaging and therapy.

19 ity of the 2009 Appropriate Use Criteria for radionuclide imaging and whether physicians at various l

20 who were referred for exercise testing with radionuclide imaging, and 21 healthy volunteers, were en

21 noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enh

22 ography, small-bowel transit measurements by radionuclide imaging, and enteroscopy.

23 Finally, the visual quality of radionuclide imaging can be improved with corrections fo

24 Radionuclide imaging can be particularly useful if MR im

25 d chest radiograph, computed tomogram scans, radionuclide imaging, diagnostic cardiac catheterization

26 a noninvasive fashion using current clinical radionuclide imaging equipment.

27 w and regional metabolism can be assessed by radionuclide imaging, especially SPECT and PET.

28 c considerations in breast cancer and covers radionuclide imaging for detection and staging.

29 considerations in breast cancer and covered radionuclide imaging for detection and staging.

30 Noninvasive radionuclide imaging has the potential to identify and a

31 response to etanercept could be monitored by radionuclide imaging in arthritic mice.

32 The role of echocardiography or radionuclide imaging in the management and monitoring of

33 f NIS expression is sufficient to facilitate radionuclide imaging in vivo.

34 ted alterations of molecular phenotype using radionuclide imaging is a noninvasive approach to strati

35 ty for the 2009 Appropriate Use Criteria for radionuclide imaging is modest, and there is considerabl

36 Noninvasive radionuclide imaging is well suited to dynamically track

37 Other cardiac imaging for which radionuclide imaging might be substituted was similarly

38 n in vivo has been well studied by using the radionuclide imaging modalities in various preclinical t

39 Part 2 will cover radionuclide imaging of breast cancer response to therap

40 Part 2 covers radionuclide imaging of breast cancer response to therap

41 Radionuclide imaging of cancer-associated molecular alte

42 This review addresses recent work on radionuclide imaging of cardiovascular inflammation, inf

43 y was to evaluate the feasibility of in vivo radionuclide imaging of IGF-1R expression in prostate ca

44 Radionuclide imaging of IGF-1R in tumors might be used f

45 Noninvasive radionuclide imaging of inflammation is feasible by MCP-

46 y was to evaluate the feasibility of in vivo radionuclide imaging of PDGFRbeta expression using an Af

47 strate, for the first time, fluorescence and radionuclide imaging of sialylated glycans in a murine t

48 verity of inflammation were also assessed by radionuclide imaging of the neutrophil-avid tracer 99mTc

49 cted using a realistic physical model of the radionuclide imaging process including nonideal collimat

50 volume errors by mathematically modeling the radionuclide imaging process.

51 Appropriate Use Criteria (AUC) published for radionuclide imaging (RNI), stress echocardiography (Ech

52 a scintillating balloon-enabled fiber-optic radionuclide imaging (SBRI) system to improve the sensit

53 External radionuclide imaging showed a two- to sixfold increase i

54 Presently, radionuclide imaging such as PET and SPECT is not used i

55 Breast-dedicated radionuclide imaging systems show promise for increasing

56 Radionuclide imaging techniques are both useful and reli

57 To evaluate the usefulness of radionuclide imaging techniques for presurgical evaluati

58 limitations of broad clinical application of radionuclide imaging, this technology has a great impact

59 Radionuclide imaging was performed immediately after int

60 ow reductions of > or =50% not identified by radionuclide imaging were apparent in MRFP full-thicknes

61 Radionuclide imaging with [(18)F]BF4(-) (PET/CT) was com